RT Journal Article
SR Electronic
T1 WITHDRAWN: Prevalence of coronary artery disease among COVID-19 patients: a systematic review and meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.01.23290768
DO 10.1101/2023.06.01.23290768
A1 Akhtar, Naushaba
A1 Padhi, Bijaya Kumar
A1 Shamim, Muhammad Aaqib
A1 Gandhi, Nandhni Chiruganam
A1 Satapathy, Prakisini
A1 Pati, Sanghamitra
A1 Nowrouzi-Kia, Behdin
A1 Chattu, Vijay Kumar
YR 2023
UL http://medrxiv.org/content/early/2023/10/23/2023.06.01.23290768.abstract
AB The authors have withdrawn their manuscript owing to a complete change in methods and results. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the first author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYes, Naushaba Akhtar received Indian Council of Medical Research – Senior Research Fellow award [CTU/Fellowship/03/2022-ECD-II - 5th May 2022] https://main.icmr.nic.in/ No, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes